title: Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
authors.affiliation: Peking University People's Hospital, Beijing, China.
authors.forename: Hong-Hu
authors.initials: HH
authors.lastname: Zhu
authors.affiliation: First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
authors.forename: De-Pei
authors.initials: DP
authors.lastname: Wu
authors.affiliation: First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Jin
authors.affiliation: First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
authors.forename: Jian-Yong
authors.initials: JY
authors.lastname: Li
authors.affiliation: Harbin Institute of Haematology and Oncology, Harbin, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Ma
authors.affiliation: Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
authors.forename: Jian-Xiang
authors.initials: JX
authors.lastname: Wang
authors.affiliation: Rui Jin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
authors.forename: Sai-Juan
authors.initials: SJ
authors.lastname: Chen
authors.affiliation: Peking University People's Hospital, Beijing, China. xjhrm@medmail.com.cn.
authors.forename: Xiao-Jun
authors.initials: XJ
authors.lastname: Huang
mesh_terms: D000328:Adult; D001151:Arsenic / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012074:Remission Induction; D016019:Survival Analysis; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D014212:Tretinoin; D001151:Arsenic
keywords: acute promyelocytic leukaemia; all-trans retinoic acid; arsenic